Immune system suppression

"Immune system suppression" refers broadly to the reduction in activity or effectiveness of the body's immune responses. This state can occur naturally—such as during pregnancy or after exposure to certain pathogens—or be induced therapeutically using drugs called immunosuppressants. The purpose may be beneficial—for example, preventing organ transplant rejection or treating autoimmune diseases—but it also increases vulnerability to infections and some cancers. Mechanistically, immune system suppression involves multiple cellular and molecular players including regulatory T cells (Tregs) which secrete inhibitory cytokines like IL‑10 and transforming growth factor beta (TGF‑β), myeloid-derived suppressor cells (MDSCs) which inhibit effector lymphocytes via similar mediators, surface molecules such as CD47 that dampen innate immunity, and other checkpoints within both innate and adaptive arms. Therapeutic agents achieve this effect by interfering at various points in these pathways—blocking activation signals required for lymphocyte proliferation/functionality; promoting expansion/activity of suppressive cell types; inhibiting pro-inflammatory cytokines; among others. Because “immune system suppression” encompasses diverse mechanisms rather than representing one discrete molecule/receptor/target structure—and because it cannot serve directly as a canonical drug target—the entry should be flagged as non-specific/inaccurate per your conventions.

Other names

ImmunosuppressionSuppressed immune response

Drugs achieve immune system suppression through mechanisms such as: Inhibition of T cell activation/proliferation; Blockade of cytokine signaling pathways; Depletion or functional inhibition of lymphocytes; Enhancement of regulatory cell populations like Tregs.